PALISADES MEDICAL CENTER — History
CCN 310003 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$191M
Latest Revenue (FY2022)
+12.8%
Revenue CAGR (3yr)
-2.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $150M | $159M | $191M | +19.5% | +12.8% |
| Operating Expenses | $185M | $200M | $196M | -2.0% | +3.0% |
| Operating Margin | -23.2% | -25.2% | -2.7% | +89.3% | +0.0% |
| Net Income | $-35M | $-40M | $-5M | +87.2% | +0.0% |
| Licensed Beds | 186 | 186 | 186 | +0.0% | +0.0% |
| Total Patient Days | 32,729 | 31,596 | 31,852 | +0.8% | -1.3% |
| Medicare Day % | 28% | 26% | 25% | -3.8% | -4.5% |
| Medicaid Day % | 9% | 9% | 7% | -17.8% | -9.3% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +27.2% ($150M → $191M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+12.8%
This Hospital
+7.6%
State Avg
Latest Margin
-2.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $211M | 7.6% |
| FY2024 (proj) | $231M | 17.8% |
| FY2025 (proj) | $252M | 28.1% |